Mücahit Yetim

Dr. Mücahit Yetim


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2025 in Exploration of Cardiology
Verified
Journal Article
Open access
PDF file
MÇMuhammet Cihat Çelik
Muhammet Cihat Çelik
MKMacit Kalçık
Macit Kalçık
ABAbdülmelik Birgün
Abdülmelik Birgün
MYMücahit Yetim
Mücahit Yetim
LBLütfü Bekar
Lütfü Bekar
YKYusuf Karavelioğlu
Yusuf Karavelioğlu
Cardiovascular aging is characterized by progressive endothelial dysfunction and arterial stiffening, two interrelated processes underlying the increased risk of hypertension, coronary artery disease, heart failure, and atrial fibrillation in older individuals. Endothelial dysfunction results from reduced nitric oxide bioavailability, increased oxidative stress, chronic low-grade inflammation, and accumulation of senescent endothelial cells that secrete pro-inflammatory mediators. In parallel, structural alterations of the vascular wall, including elastin fragmentation, collagen deposition, cross-linking by advanced glycation end products, vascular smooth muscle cell phenotypic switching, and calcification, lead to increased stiffness and impaired vascular compliance. These maladaptive changes reinforce one another, creating a vicious cycle in which dysfunctional endothelium accelerates stiffening, while mechanical alterations in turn amplify endothelial injury. Molecular pathways involving NADPH oxidases, mitochondrial dysfunction, NF-κB, JAK/STAT, AMPK, mTOR, sirtuins, and epigenetic regulators integrate oxidative, inflammatory, and metabolic signals that shape vascular aging. Clinically, endothelial dysfunction and vascular stiffness predict cardiovascular events independent of traditional risk factors and serve as emerging biomarkers of biological vascular age. Established therapies such as statins, renin-angiotensin system blockade, structured exercise, and dietary interventions improve vascular function, while novel approaches targeting senescence and redox imbalance are under investigation. Understanding these mechanisms provides opportunities to mitigate vascular aging and extend cardiovascular health span.

18 September 2025 in The Clinical Respiratory Journal
Verified
Journal Article
Open access
MYMücahit Yetim
Mücahit Yetim
MKMacit Kalçık
Macit Kalçık
LBLütfü Bekar
Lütfü Bekar
YKYusuf Karavelioğlu
Yusuf Karavelioğlu
YYYasemin Arı Yılmaz
Yasemin Arı Yılmaz
Introduction: Obstructive sleep apnea (OSA) is a prevalent disorder characterized by recurrent upper airway collapse, resulting in intermittent hypoxia and sleep fragmentation. While obesity is a major risk factor, traditional markers such as body mass index (BMI) inadequately reflect the complex interplay of body composition in OSA pathogenesis. This study aimed to investigate the predictive value of body composition parameters assessed by bioelectrical impedance analysis (BIA) for OSA.Methods: In this cross‐sectional single‐center study, 78 patients diagnosed with OSA by polysomnography (PSG) and 78 age‐, gender‐, and BMI‐matched controls without OSA were analyzed. BIA was used to assess fat distribution, muscle mass, and body water composition. Logistic regression analyses were performed to identify independent predictors of OSA.Results: Compared to controls, the OSA group had significantly higher lean mass, trunk fat percentage, and total body water. Multivariable logistic regression identified body fat mass (OR = 1.06), visceral fat area (OR = 0.83), and total body water (OR = 1.10) as independent predictors of OSA. Notably, total body water had the strongest association with OSA risk, independent of traditional obesity metrics.Conclusion: BIA‐derived body composition analysis provides nuanced insights beyond BMI, highlighting the roles of central fat distribution and fluid balance in OSA pathophysiology. These findings underscore the clinical utility of incorporating detailed body composition assessment into the routine evaluation of patients at risk for OSA.

27 September 2025 in Journal of Human Hypertension
Verified
Journal Article
Closed access
PDF file
ASAbdullah Sarıhan
Abdullah Sarıhan
MKMacit Kalçık
Macit Kalçık
MYMücahit Yetim
Mücahit Yetim

1 December 2025 in Exploration of Cardiology
Verified
Journal Article
Open access
ABAbdülmelik Bi̇rgün
Abdülmelik Bi̇rgün
MÇMuhammet Cihat Çeli̇k
Muhammet Cihat Çeli̇k
MKMacit Kalçık
Macit Kalçık
MYMücahit Yetim
Mücahit Yetim
LBLütfü Bekar
Lütfü Bekar
YKYusuf Karaveli̇oğlu
Yusuf Karaveli̇oğlu
Diabetes mellitus is one of the leading global health concerns, with an increasing burden of cardiovascular morbidity and mortality. Sexual dysfunction and peripheral artery disease are two frequent and interrelated complications in diabetic populations, both serving as potential indicators of systemic vascular and neural damage. The interplay of endothelial dysfunction, atherosclerosis, and diabetic neuropathy provides a mechanistic basis linking these complications with heightened cardiovascular risk. While sexual dysfunction is often underrecognized, it may represent an early marker of vascular impairment. Peripheral artery disease, on the other hand, is a well-established predictor of major cardiovascular events. Patient-centered education and comprehensive management approaches are essential to address these issues and improve outcomes. This narrative review synthesizes current evidence on vascular and neural mechanisms underlying sexual dysfunction and peripheral artery disease in diabetes, highlighting their clinical relevance and implications for cardiovascular risk stratification.

24 April 2026 in Exploration of Cardiology
Verified
Journal Article
Open access
PDF file
ÖÇÖmer Burak Çelik
Ömer Burak Çelik
MKMacit Kalçık
Macit Kalçık
ASAbdullah Sarıhan
Abdullah Sarıhan
MYMehmet Mustafa Yılmaz
Mehmet Mustafa Yılmaz
OKOsman Karaarslan
Osman Karaarslan
YKYusuf Karavelioğlu
Yusuf Karavelioğlu
High-sensitivity cardiac biomarkers have transformed modern cardiology by enabling earlier diagnosis and refined risk stratification in acute coronary syndromes and heart failure. However, increasing analytical sensitivity has also amplified the clinical impact of immunoassay interferences, particularly those caused by heterophile antibodies. These endogenous antibodies can interact with assay antibodies and generate false-positive or false-negative results, most notably in sandwich immunoassays used for cardiac troponins and natriuretic peptides. Persistent, clinically implausible biomarker elevations related to heterophile antibody interference have led to unnecessary invasive procedures, inappropriate pharmacologic treatment, repeated hospital admissions, and prolonged diagnostic uncertainty. Conversely, false-negative results may delay diagnosis, result in inappropriate discharge, and contribute to adverse clinical outcomes in high-risk patients. This review summarizes the immunological basis and analytical mechanisms of heterophile antibody interference, highlights cardiac biomarkers most commonly affected, and outlines key clinical red flags that should prompt suspicion. Practical laboratory strategies include polyethylene glycol precipitation as an initial approach to detect antibody-mediated interference, followed by dilution studies, heterophile blocking reagents, and cautiously interpreted alternative platform testing within assay-specific reference frameworks, together with close clinician-laboratory collaboration. Greater awareness of analytical interference is critical as cardiology becomes increasingly biomarker-driven. Integrating clinical judgment with structured laboratory verification can substantially reduce diagnostic error, improve patient safety, and prevent avoidable healthcare utilization in contemporary cardiovascular practice.

31 January 2026 in Angiology
Verified
Journal Article
Closed access
ASAbdullah Sarıhan
Abdullah Sarıhan
LBLütfü Bekar
Lütfü Bekar
MYMücahit Yetim
Mücahit Yetim
MÇMuhammet Cihat Çelik
Muhammet Cihat Çelik
MKMacit Kalçık
Macit Kalçık
YKYusuf Karavelioğlu
Yusuf Karavelioğlu
This study examined the association between a blunted nocturnal heart rate decline and ventricular arrhythmias, echocardiographic findings, and clinical characteristics in patients with isolated hypertension (defined as hypertension in the absence of other systemic comorbidities). A total of 229 adults who underwent transthoracic echocardiography and 24-hour Holter monitoring were retrospectively evaluated. Patients were classified as dippers (≥10% nocturnal heart rate reduction; n = 170) or non-dippers (<10% reduction; n = 59), and were also compared according to Lown classes 0 versus 1-4. Baseline demographics, laboratory parameters, and antihypertensive treatments were similar between groups. Non-dippers demonstrated greater interventricular septal and posterior wall thickness, higher left ventricular mass and mass index, and a higher prevalence of left ventricular hypertrophy and concentric hypertrophy ( P < .05 for all). They also exhibited more frequent ventricular and atrial ectopy. Patients in Lown classes 1-4 had higher systolic blood pressure, more pronounced left ventricular remodeling, and a greater arrhythmic burden. In multivariable analysis, concentric hypertrophy (Odds Ratio [OR]: 2.682; P = .034) and non-dipping nocturnal heart rate (OR: 9.254; P = .001) were independent predictors of arrhythmias. These findings suggest that non-dipping nocturnal heart rate (reflecting impaired parasympathetic activity and relative sympathetic predominance) is associated with adverse cardiac remodeling and increased arrhythmia risk in isolated hypertension.